PIERIS PHARMACEUTICALS, INC. (PIRS) Income Tax Expense (Benefit) USD 2014 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pieris Pharmaceuticals, Inc. annual/quarterly Income Tax Expense (Benefit) history and growth rate from 2014 to 2023.
  • Pieris Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending December 31, 2019 was $0.000.
  • Pieris Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending December 31, 2019 was $0.000.
  • Pieris Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2023 was $0.000.
  • Pieris Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $0.000.
  • Pieris Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000, a 100% decline from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $0 $0 Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $0 -$164 K -100% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 $164 K +$164 K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $0 +$312 K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2018 -$312 K -$1.42 M -128% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-13
2017 $1.1 M +$941 K +581% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $162 K -$41.9 K -20.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $204 K +$204 K Jan 1, 2015 Dec 31, 2015 10-K 2017-03-30
2014 -$18 Jan 1, 2014 Dec 31, 2014 10-K 2016-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.